Compare ADMA Biologics Inc (ADMA) vs Manchester United PLC (MANU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Manchester United PLC — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Manchester United PLC trades at $22.23 (market cap $3.80B). The key difference: Manchester United PLC is the larger of the two by market cap, and Manchester United PLC pays a 1.26% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | MANU | |
|---|---|---|
Market Cap | $2.22B | $3.80B |
Sector | Health | Media |
52-Week High | $20.38 | $23.53 |
52-Week Low | $7.60 | $15.10 |
Enterprise Value | $2.29B | $4.74B |
Dividend Yield | — | 1.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →
